当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 资产负债表

康泰医学

(300869)

  

流通市值:23.53亿  总市值:35.84亿
流通股本:2.64亿   总股本:4.02亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金982,572,469.51,064,439,785.521,041,280,114.13982,722,811.09
  交易性金融资产832,307,184.75812,346,742.58762,353,589.43631,773,267.48
  应收票据及应收账款47,385,309.9241,569,97336,477,045.4750,045,443.04
  其中:应收票据---0
        应收账款47,385,309.9241,569,97336,477,045.4750,045,443.04
  预付款项9,409,790.278,542,577.449,329,948.37,551,950.04
  其他应收款合计18,655,036.8221,037,655.2910,307,655.37,082,216.1
  存货224,313,743.37210,331,072.11236,620,428.47229,580,801.36
  一年内到期的非流动资产-22,872,749.78249,850,214.28411,740,927.18
  其他流动资产40,039,842.7235,984,352.622,805,755.8423,253,638.6
  流动资产合计2,154,683,377.352,217,124,908.322,369,024,751.222,343,751,054.89
非流动资产:
  投资性房地产58,184,047.5658,942,840.9459,579,141.5460,215,442.14
  固定资产191,271,658.98194,561,881.99198,913,281.59203,253,388.04
  在建工程107,082,283.05106,955,688.22106,104,575.69102,298,519.05
  使用权资产2,445,574.522,820,817.653,196,060.783,577,051.45
  无形资产47,637,696.5148,321,829.5949,007,953.8349,695,552.9
  长期待摊费用30,092.3435,572.0841,051.8246,531.56
  递延所得税资产9,046,122.048,480,062.047,960,620.047,134,495.83
  其他非流动资产1,055,912.561,539,353.46535,194.351,220,163.38
  非流动资产合计416,753,387.56421,658,045.97425,337,879.64427,441,144.35
  资产总计2,571,436,764.912,638,782,954.292,794,362,630.862,771,192,199.24
流动负债:
  短期借款45,000,00095,000,000224,575,849.63215,000,000
  应付票据及应付账款31,648,241.0426,613,552.9721,922,373.4611,465,549.27
        应付账款31,648,241.0426,613,552.9721,922,373.4611,465,549.27
  合同负债33,328,234.5139,110,063.9440,134,00230,629,857.47
  应付职工薪酬11,789,356.5714,621,856.3111,133,365.2712,232,117.62
  应交税费687,277.68697,145.511,023,086.061,850,261.76
  其他应付款合计3,588,529.454,419,247.063,881,970.727,236,242.39
  一年内到期的非流动负债955,275.561,048,522.571,148,159.361,082,159.53
  流动负债合计126,996,914.81181,510,388.36303,818,806.5279,496,188.04
非流动负债:
  应付债券762,647,070.12766,377,762.72757,689,095.64749,141,453.98
  租赁负债1,214,899.11,758,759.51,847,486.172,258,289.25
  递延收益6,547,619.66,699,397.86,853,049.177,088,500.22
  递延所得税负债68,171.282,635.6449,249.6458,155.81
  非流动负债合计770,477,760.1774,838,555.66766,438,880.62758,546,399.26
  负债合计897,474,674.91956,348,944.021,070,257,687.121,038,042,587.3
所有者权益(或股东权益):
  实收资本(或股本)401,804,087401,804,051401,803,327401,803,197
  其他权益工具29,612,318.5429,612,371.2529,613,425.4629,613,615.22
  资本公积352,373,282.61352,372,186.62352,350,423.02352,346,523.87
  其他综合收益768,972.421,227,502.751,893,656.292,700,393.92
  专项储备4,697,342.354,697,342.354,697,342.354,697,342.35
  盈余公积174,456,618.55174,456,618.55174,456,618.55174,456,618.55
  未分配利润710,249,468.53718,263,937.75759,290,151.07767,531,921.03
  归属于母公司股东权益合计1,673,962,0901,682,434,010.271,724,104,943.741,733,149,611.94
  股东权益合计1,673,962,0901,682,434,010.271,724,104,943.741,733,149,611.94
  负债和股东权益合计2,571,436,764.912,638,782,954.292,794,362,630.862,771,192,199.24
公告日期2026-10-302026-08-282026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑